GeneDx Secures $100M Blackstone Term Loan for Debt Refinancing
Summary
GeneDx Holdings Corp. has secured a new $100 million five-year secured term loan facility from Blackstone, effective February 27, 2026. The proceeds will be used to repay and terminate its existing credit facility, optimizing the company's balance sheet and enhancing liquidity. This strategic refinancing, which includes a $50 million minimum liquidity covenant, follows the company's recent strong financial performance in Q4 and full-year 2025. The new loan bears interest at Term SOFR plus 4.50% and is secured by a first-lien on substantially all assets, signaling a continued focus on strengthening its financial position.
At the time of this announcement, WGS was trading at $79.41 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $55.17 to $170.87. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Unknown.